| 产品详情 |
| Edit |   |
|---|
| Product Name | Glucagon-like Peptide 1, CT, Control Peptide (GLP1) |
|---|
| Description | 9aa C-terminal peptide of human GLP1. Corresponding antibody G2040-36A recognizes human GLP1. The 9aa human peptide is 100% conserved in mouse, rat, guinea pig, bovine and porcine. No significant sequence homology is detected with other proteins. GLP1, a processed active peptide of 30aa (chr 2q36-q37) is a potent insulin secretagogue, plays a major role in the enteroinsular axis, accounting for the finding that plasma insulin levels accompanying oral intake of glucose are greater than those observed when glucose is given intravenously. The so-called gluco-incretin. Glucagon is a member of a multigene family comprising of Secretin, Vasoactive Intestinal Peptide (VIP), Gastric Inhibitory Peptide (GIP) and others like Glicentin and Oxyntomodulin (OXM), which differs from glucagon by C-terminal octapeptide. The glucagon precursor contains at least 3 intervening sequences that divide the protein-coding portion into 4 regions corresponding to the signal peptide and part of the N-terminal pep |
|---|
| Size | 100ug |
|---|
| Concentration | n/a |
|---|
| Applications | ELISA WB |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | G2040-36B |
|---|
| Price | |
|---|
| Order / More Info | Glucagon-like Peptide 1, CT, Control Peptide (GLP1) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|